Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled study of dinalbuphine sebacate injection for postoperative pain after abdominal surgery
CTR20210376Phase 3Active
- Sponsor
- Shun Tian Medical & Biotechnology
- Start
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dinalbuphine sebacate in acute postoperative pain, sponsored by Shun Tian Medical & Biotechnology. Started Jun 2021; status: active.
02
Drugs
dinalbuphine sebacate
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on CTR20210376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210376.